Biotechnology policies and performance in central and eastern Europe
by Jacqueline Senker, Christien Enzing, Thomas Reiss
International Journal of Biotechnology (IJBT), Vol. 10, No. 4, 2008

Abstract: This paper assesses how far ten Central and Eastern European (CEE) countries have 'caught up' in biotechnology on the basis of information about the policies and funding for biotechnology research and commercialisation from 2002–2005 and on the research and commercialisation performance of these countries. The countries that are covered are Bulgaria, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, the Slovak Republic and Slovenia. The countries are grouped into three clusters, with similar performances in biotechnology as the basis for distinguishing the shared characteristics which could explain performance. Government science and technology policy is found to be a significant factor in explaining biotechnology performance.

Online publication date: Wed, 16-Jul-2008

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com